| All active patients (n = 1 891 623) | Patients prescribed pregabalin (n = 114 123) | ||
|---|---|---|---|
| n (%) | n (%) | Percentage of active patients, % (95% CI)a | |
| Sex | |||
| Female | 1 087 939 (57.5) | 68 311 (59.9) | 6.3 (5.9 to 6.6) |
| Male | 800 676 (42.3) | 45 769 (40.1) | 5.7 (5.4 to 6.0) |
| Missing | 3008 (0.2) | 43 (0.0) | 1.4 (0.8 to 2.0) |
| Rurality of patient residence | |||
| Major city | 1 204 426 (63.7) | 63 456 (55.6) | 5.3 (4.9 to 5.6) |
| Inner regional | 440 727 (23.3) | 33 852 (29.7) | 7.7 (7.0 to 8.3) |
| Outer regional | 200 543 (10.6) | 14 706 (12.9) | 7.3 (6.5 to 8.2) |
| Remote | 29 386 (1.6) | 1325 (1.2) | 4.5 (3.2 to 5.8) |
| Very remote | 5932 (0.3) | 297 (0.3) | 5.0 (3.4 to 6.6) |
| Missing | 10 609 (0.6) | 486 (0.4) | 4.6 (3.9 to 5.3) |
| Socioeconomic status of patient residence (IRSAD quintiles) | |||
| 1 (most disadvantaged) | 304 870 (16.1) | 25 821 (22.6) | 8.5 (7.9 to 9.1) |
| 2 | 291 603 (15.4) | 19 685 (17.2) | 6.8 (6.3 to 7.2) |
| 3 | 422 368 (22.3) | 27 975 (24.5) | 6.6 (6.1 to 7.1) |
| 4 | 375 468 (19.8) | 18 461 (16.2) | 4.9 (4.5 to 5.3) |
| 5 (least disadvantaged) | 480 485 (25.4) | 21 421 (18.8) | 4.5 (4.0 to 4.9) |
| Missing | 16 829 (0.9) | 760 (0.7) | 4.5 (3.8 to 5.2) |
aConfidence intervals adjusted for clustering.